Indegene Partners with Microsoft to Integrate Gen AI in Healthcare

The collaboration, disclosed in a company filing on Thursday, aims to empower global life sciences companies with enterprise-grade GenAI services for faster innovation.

Indegene, a provider of digitally enabled commercialization services for the life sciences sector, has partnered with Microsoft to leverage GenAI for the medical industry.

The collaboration, disclosed in a company filing on Thursday, aims to empower global life sciences companies with enterprise-grade GenAI services for faster innovation.

Highlighting GenAI's potential in transforming life sciences operations, Tarun Mathur, CTO, Indegene, said, "GenAI presents a once-in-a-decade opportunity for life sciences companies to modernize business processes and reimagine the effectiveness and efficiency of their operations throughout the value chain. Using GenAI, we're closely working with many of our clients to solve specific business problems, with nearly 50 real-world use cases already in an advanced pilot stage.”

The collaboration focuses on co-innovating generative AI services and workflows across commercial, medical, regulatory, and clinical functions.

"With a focus on the right use cases, a responsible and compliant approach to scaling up, and shared learnings, we put generative AI to work for our clients," added Mathur.

One of the key initiatives under this partnership is the Content Super App, which utilizes OpenAI’s Azure OpenAI Service. This modular content value chain streamlines content creation and tagging for life sciences companies, providing a comprehensive view of the content process.

The app aims to enhance content creation speed, personalize content, and introduce new conversation formats. Additionally, it facilitates creative and video transformation, effectively engaging healthcare professionals, patients, and payers.

Indegene's solutions accelerate the authoring of key documents such as clinical study reports (CSRs) and protocols by sourcing content from relevant literature, ensuring compliance across clinical and regulatory domains.

Impact on Data Management & Analytics

Reportedly, Indegene's solutions, powered by Microsoft Fabric, enhance data ingestion and refinement processes. This streamlines reporting and ensures governance, compliance adherence, and agility in business operations, providing a competitive edge in the marketplace.

Emphasizing the broader implications of generative AI in the healthcare sector, Alok Lall, COO of Microsoft India & South Asia, said, "Generative AI is profoundly shaping every industry, including life sciences, by offering unprecedented avenues for healthcare technology advancements. According to a Microsoft-commissioned study conducted by IDC, a staggering 79 percent of healthcare organizations have now embraced AI. This demonstrates that the tangible business value of this transformation is indisputable."

By focusing on real-world applications and compliance, the collaboration aims to enhance the efficiency and effectiveness of life sciences companies, ultimately benefiting healthcare professionals and patients alike.